Home
>
US Stocks
>
Tricida Inc
Tricida Inc
TCDA

Tricida Inc (TCDA)

$4.511.94%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
4.47
Today Low/High
4.47 / 4.5
52 Week Low/High
$3.55 / $14.68
Market Cap
$201.21M

Company Details

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Tricida is currently conducting a renal outcomes clinical trial, VALOR-CKD, to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. There are no FDA-approved treatments for chronic metabolic acidosis, a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. It is estimated to pose a health risk to approximately three million patients with CKD in the United States.
Organisation
Tricida Inc
Headquaters
South San Francisco, California, US
Employees
64
Industry
Health Technology
CEO
Gerrit Klaerner

Discover more

Frequently Asked Questions

What is Tricida Inc (TCDA) share price today?

Can Indians buy Tricida Inc (TCDA) shares?

How can I buy Tricida Inc (TCDA) shares from India?

Can Fractional shares of Tricida Inc (TCDA) be purchased?

What are the documents required to start investing in Tricida Inc (TCDA) stocks?

We are a SEBI registered investement advisor